Neuromodulation Market ( by Technology , Applications Segment , Region and Company ) and Forecast to 2021 - Global Analysis
Neuromodulation Market ( by Technology , Applications Segment , Region and Company ) and Forecast to 2021 - Global Analysis
The global neuromodulation market is poised to cross US $ 5 Billion mark by 2021 . Neuromodulation is a technology that acts directly upon nerves . It is the alteration-or modulation-of nerve activity by delivering electrical or pharmaceutical agents directly to a target area . Neuromodulation devices and treatments are life changing . They affect every area of the body and treat nearly every disease or symptom from headaches to tremors to spinal cord damage to urinary incontinence . With such a broad therapeutic scope , and significant ongoing improvements in biotechnology , the neuromodulation is poised as a major growth industry for the next decade . The market growth is attributed to factors such as an increased adoption of neuromodulation devices , ageing population , rising prevalence of diseases relevant to neuromodulation , technological advancements and deal making activity globally . However , the factors such as regulatory standards and compliance , negative social perception and a dearth of skilled neurosurgeons are restraining the growth of neuromodulation market globally .
By Technology Neuromodulation Market Analysis - In terms of technology , Spinal cord stimulation ( SCS ) is the largest segment of the market and is mostly indicated for treatment of chronic pain . Deep brain stimulation ( DBS ) represents the second largest segment within the neuromodulation market being followed by Sacral nerve stimulation ( SNS ) at the third spot in 2015 . The VNS segment stands at the fourth spot with around XX % share of the neuromodulation market in 2015 . .